跳至主要内容
临床试验/CTRI/2016/07/007089
CTRI/2016/07/007089已完成未知

An open label single group single centre study to evaluate the safety and efficacy of Pterostilbene, Garcinol and Anthocyanin combination for weight management in adult male and/or female obese or overweight patients.

Sami Labs Limited0 个研究点目标入组 36 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
36

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Male or female patients.
  • 2. Age between 20 to 65 years.
  • 3. BMI between > 25 to 40 Kg/m
  • 4. Willing to come for regular follow-up visits.
  • 5. Able to give written informed consent.

排除标准

  • 1. Intake of over the counter weight loss agents, centrally acting appetite suppressants in the
  • previous six months.
  • 2. Pathophysiologic / genetic syndromes associated with obesit y (Cushingâ??s syndrome,
  • Turnerâ??s syndrome, Prader willi syndrome).
  • 3. Patients with evidence of malignancy.
  • 4. Patients with poorly controlled Hypertension ( > 160/100 mm Hg).
  • 5. Patients on prolonged ( >6 weeks) medication with corticosteroids, antidepressants,
  • anticholinergics, etc. or any other drugs that may have an influence on the outcome of the
  • 6. Symptomatic patient with clinical evidence of Heart failure.
  • 7. Patients with concurrent serious hepatic disorder (defined as Aspartate Amino
  • Transferase (AST) and /or Alanine Amino Transferase (ALT), Total Bilirubin, Alkaline
  • Phosphatase (ALP) > 2.5 times upper normal limit or Renal Disorders (defined as Serum
  • Creatinine > 1.2 mg/dL, Severe Pulmonary Dysfunction (uncontrolled Bronchial Asthma
  • and /or Chronic Obstructive Pulmonary Disease [COPD], or any other condition that may
  • jeopardize the study.
  • 8. History of HIV and other viral infections.
  • 9. Alcoholics and/or drug abusers.
  • 10. Prior surgical therapy for obesity.
  • 11. History of hypersensitivity to any of the herbal extracts or dietary supplement.
  • 12. Pregnant / lactating woman.
  • 13. Patients who participated in any other clinical trial during the past six (06) months.
  • 14. Any other condition which the Principal Investigator thinks may jeopardize the study.

研究者

发起方
Sami Labs Limited

相似试验